MeiraGTx Holdings plc
MGTXNASDAQHealthcare● Active
$9.08
+$0.08(+0.89%)
Market Cap$840894260
P/E Ratio—
52W High$11.85
52W Low$5.235
MeiraGTx Holdings plc (MGTX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MGTX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.57
Est. -$0.43 · -32.6%
Revenue
$0.00B
Est. $0.02B · -98.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
MGTX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.31 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 14, 2026 | -$0.43 | -$0.57 | -32.6% | $0.00B | $0.02B | -98.3% |
| ▲ Q1 FY2026 | Mar 26, 2026 | -$0.60 | $0.19 | +131.7% | $0.08B | $0.00B | +5115.3% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -$0.50 | -$0.62 | -24.0% | $0.00B | $0.00B | -89.4% |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$0.52 | -$0.48 | +7.7% | $0.00B | $0.01B | -43.1% |
| ▼ Q2 FY2025 | May 13, 2025 | -$0.38 | -$0.51 | -34.2% | $0.00B | $0.00B | -56.6% |
| ▼ Q1 FY2025 | Mar 13, 2025 | -$0.48 | -$0.50 | -4.2% | $0.02B | $0.00B | +1326.0% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -$0.47 | -$0.54 | -14.9% | $0.01B | $0.00B | +573.5% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.31
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
-$0.57
EPS Est.
-$0.43
EPS Surpr.
-32.6%
Revenue
$0.00B
Q1 FY2026
Mar 26, 2026Beat
EPS Actual
$0.19
EPS Est.
-$0.60
EPS Surpr.
+131.7%
Revenue
$0.08B
Q4 FY2025
Nov 13, 2025Miss
EPS Actual
-$0.62
EPS Est.
-$0.50
EPS Surpr.
-24.0%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$0.48
EPS Est.
-$0.52
EPS Surpr.
+7.7%
Revenue
$0.00B
Q2 FY2025
May 13, 2025Miss
EPS Actual
-$0.51
EPS Est.
-$0.38
EPS Surpr.
-34.2%
Revenue
$0.00B
Q1 FY2025
Mar 13, 2025Miss
EPS Actual
-$0.50
EPS Est.
-$0.48
EPS Surpr.
-4.2%
Revenue
$0.02B
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$0.54
EPS Est.
-$0.47
EPS Surpr.
-14.9%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.32 | $0.33 | $0.35 | 2 |
| Q3 FY2027 | $-0.58 | $-0.56 | $-0.54 | 1 |
| Q2 FY2027 | $-0.56 | $-0.53 | $-0.51 | 1 |
| Q1 FY2027 | $-0.53 | $-0.51 | $-0.49 | 2 |
| Q4 FY2026 | $-0.36 | $-0.35 | $-0.33 | 2 |
| Q3 FY2026 | $-0.56 | $-0.51 | $-0.45 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -32.6% | $9.97 | $9.95 | -0.20% |
| ▲ Q1 FY2026 | Mar 26, 2026 | +131.7% | $7.62 | $7.53 | -1.18% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -24.0% | $8.66 | $8.26 | -4.62% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +7.7% | $8.34 | $8.33 | -0.12% |
| ▼ Q2 FY2025 | May 13, 2025 | -34.2% | $5.62 | $5.15 | -8.36% |
| ▼ Q1 FY2025 | Mar 13, 2025 | -4.2% | $6.41 | $8.25 | +28.71% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -14.9% | $6.66 | $7.04 | +5.71% |
| ▼ Q3 FY2024 | Aug 12, 2024 | -145.2% | $4.37 | $4.00 | -8.47% |
Q2 FY2026-0.20%
Report Date
May 14, 2026
EPS Beat/Miss
-32.6%
Price Before
$9.97
Price After
$9.95
Q1 FY2026-1.18%
Report Date
Mar 26, 2026
EPS Beat/Miss
+131.7%
Price Before
$7.62
Price After
$7.53
Q4 FY2025-4.62%
Report Date
Nov 13, 2025
EPS Beat/Miss
-24.0%
Price Before
$8.66
Price After
$8.26
Q3 FY2025-0.12%
Report Date
Aug 14, 2025
EPS Beat/Miss
+7.7%
Price Before
$8.34
Price After
$8.33
Q2 FY2025-8.36%
Report Date
May 13, 2025
EPS Beat/Miss
-34.2%
Price Before
$5.62
Price After
$5.15
Q1 FY2025+28.71%
Report Date
Mar 13, 2025
EPS Beat/Miss
-4.2%
Price Before
$6.41
Price After
$8.25
Q4 FY2024+5.71%
Report Date
Nov 13, 2024
EPS Beat/Miss
-14.9%
Price Before
$6.66
Price After
$7.04
Q3 FY2024-8.47%
Report Date
Aug 12, 2024
EPS Beat/Miss
-145.2%
Price Before
$4.37
Price After
$4.00
Avg Beat Reaction-0.65%
Avg Miss Reaction+2.13%
Beat Rate2 / 8 quarters
Largest Move+28.71% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MGTX ends December
MeiraGTx Holdings plc (MGTX) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.57 — missing the analyst consensus of $-0.43 by -32.6%. The next MGTX earnings date is expected around September 1, 2026.
Each quarter, investors track MGTX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MGTX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MGTX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MGTX earnings · 5 questionsMeiraGTx Holdings plc's next earnings report is expected around September 1, 2026. MGTX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MGTX historically reports after market close (AMC).
MGTX earnings datewhen is MGTX earningsMGTX next earnings datewhen does MGTX report earningsMGTX earnings calendar
▸ Source: FMP · MeiraGTx Holdings plc SEC filings · US GAAP · MeiraGTx Holdings plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026